Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Non-esterified fatty acid |
Is a |
False |
Fatty acid |
Inferred relationship |
Some |
|
Esterified fatty acid |
Is a |
False |
Fatty acid |
Inferred relationship |
Some |
|
Fatty acid with fewer than 10 carbon atoms |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Fatty acid with 10 to 14 carbon atoms |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Fatty acid with 10 or more carbon atoms |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Propionic acid |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Saturated fatty acid (substance) |
Is a |
False |
Fatty acid |
Inferred relationship |
Some |
|
3-hydroxydodecanoate |
Is a |
False |
Fatty acid |
Inferred relationship |
Some |
|
Unsaturated fatty acid |
Is a |
False |
Fatty acid |
Inferred relationship |
Some |
|
Free fatty acids measurement |
Has measured component |
False |
Fatty acid |
Inferred relationship |
Some |
|
Fatty acid profile measurement |
Has measured component |
False |
Fatty acid |
Inferred relationship |
Some |
|
Serum free fatty acid measurement |
Has measured component |
False |
Fatty acid |
Inferred relationship |
Some |
|
Plasma free fatty acid measurement |
Has measured component |
False |
Fatty acid |
Inferred relationship |
Some |
|
Cilastatin |
Is a |
False |
Fatty acid |
Inferred relationship |
Some |
|
Free fatty acids measurement |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Fatty acid profile measurement |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Serum free fatty acid measurement |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Plasma free fatty acid measurement |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
hørolietablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Fatty acid measurement |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Serum C26 long chain fatty acid level (procedure) |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Serum C24/C22 long chain fatty acid level (procedure) |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Serum C26/C22 long chain fatty acid level (procedure) |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
lipiodol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 10 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 20 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Intravenøs fedtemulsion 30 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Product containing ethiodized oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fatty acid |
Inferred relationship |
Some |
|
Cis-4-decanoate measurement (procedure) |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Adverse reaction to fatty acid |
Causative agent |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Bicyclic fatty acid (substance) |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Unesterified fatty acid |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Fatty acid profile to detect peroxisomal defect |
Component |
True |
Fatty acid |
Inferred relationship |
Some |
1 |
Branched chain fatty acid (substance) |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Hydroxy fatty acid (substance) |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Docosatetraenoate (substance) |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Pristanate |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Sodium morrhuate |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Thioctic acid |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
3-(3-hydroxyphenyl) propanoic acid (substance) |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|
Stearamidopropyl dimethylamine (substance) |
Is a |
True |
Fatty acid |
Inferred relationship |
Some |
|